Symbols / NEUP Stock $4.41 +7.04% Neuphoria Therapeutics Inc.

Healthcare • Biotechnology • United States • NGM
NEUP (Stock) Chart
About

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105 for the treatment of cancer. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; and Kv3.1/3.2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders. The company has a collaboration with Merck & Co., Inc. to develop a7 receptor positive allosteric modulators targeting cognitive dysfunction associated with alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Burlington, Massachusetts.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 23.77M
Enterprise Value 1.64M Income -5.66M Sales 14.99M
Book/sh 5.52 Cash/sh 4.11 Dividend Yield —
Payout 0.00% Employees 7 IPO —
P/E — Forward P/E -1.15 PEG —
P/S 1.59 P/B 0.80 P/C —
EV/EBITDA -1.36 EV/Sales 0.11 Quick Ratio 8.76
Current Ratio 9.04 Debt/Eq 0.11 LT Debt/Eq —
EPS (ttm) -0.69 EPS next Y -3.85 EPS Growth —
Revenue Growth — Earnings 2026-02-17 15:00 ROA -4.25%
ROE -26.07% ROIC — Gross Margin 100.00%
Oper. Margin -12.43% Profit Margin -37.79% Shs Outstand 5.39M
Shs Float 4.17M Short Float 0.23% Short Ratio 0.21
Short Interest — 52W High 21.40 52W Low 3.65
Beta — Avg Volume 49.48K Volume 62.92K
Target Price $9.77 Recom None Prev Close $4.12
Price $4.41 Change 7.04%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.77
Mean price target
2. Current target
$4.41
Latest analyst target
3. DCF / Fair value
$-2.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.41
Low
$2.30
High
$20.00
Mean
$9.77

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-05 main HC Wainwright & Co. Buy → Buy $7
2025-09-11 main Maxim Group Buy → Buy $35
2025-08-26 reit HC Wainwright & Co. Buy → Buy $21
2025-02-04 main HC Wainwright & Co. Buy → Buy $21
News
RSS: Latest NEUP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-10-21 LYNX1 CAPITAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security — 639,110 $5.14 $3,283,108
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Revenue
0.00
0.00
-100.00%
0.18
0.00
Operating Revenue
0.00
0.00
-100.00%
0.18
0.00
Operating Expense
17.80
-17.45%
21.56
+45.07%
14.86
+65.92%
8.96
Research And Development
9.42
-27.95%
13.07
+18.77%
11.01
+154.21%
4.33
Selling General And Administration
8.47
-4.90%
8.91
+69.09%
5.27
+24.25%
4.24
General And Administrative Expense
8.47
-4.90%
8.91
+69.09%
5.27
+24.25%
4.24
Other Gand A
8.47
-4.90%
8.91
+75.09%
5.09
+54.91%
3.29
Other Operating Expenses
-0.10
+77.48%
-0.42
+70.09%
-1.41
-465.48%
0.39
Total Expenses
17.80
-17.45%
21.56
+45.07%
14.86
+65.92%
8.96
Operating Income
-17.80
+17.45%
-21.56
-46.86%
-14.68
-63.89%
-8.96
Total Operating Income As Reported
-17.89
+18.61%
-21.98
—
—
EBITDA
-17.13
+18.01%
-20.90
-45.94%
-14.32
-217.14%
-4.51
Normalized EBITDA
-19.13
+7.19%
-20.61
-48.10%
-13.92
-80.16%
-7.73
Reconciled Depreciation
0.66
-0.03%
0.66
-13.10%
0.76
-40.28%
1.28
EBIT
-17.80
+17.45%
-21.56
-42.95%
-15.08
-160.35%
-5.79
Total Unusual Items
2.00
+803.93%
-0.28
+29.12%
-0.40
-112.47%
3.21
Total Unusual Items Excluding Goodwill
2.00
+803.93%
-0.28
+29.12%
-0.40
-112.47%
3.21
Special Income Charges
—
-0.65
-1.35%
-0.65
-126.91%
2.40
Restructuring And Mergern Acquisition
—
0.65
+1.55%
0.64
+126.69%
-2.41
Net Income
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Pretax Income
-15.58
+27.61%
-21.52
-42.52%
-15.10
-126.22%
-6.68
Net Non Operating Interest Income Expense
0.22
-31.89%
0.32
+1469.75%
-0.02
+97.82%
-1.08
Interest Expense Non Operating
—
0.01
-23.81%
0.02
-97.90%
0.88
Net Interest Income
0.22
-31.89%
0.32
+1469.75%
-0.02
+97.82%
-1.08
Interest Expense
—
0.01
-23.81%
0.02
-97.90%
0.88
Interest Income Non Operating
0.22
-31.89%
0.32
+4660.04%
0.01
+56.98%
0.00
Interest Income
0.22
-31.89%
0.32
+4660.04%
0.01
+56.98%
0.00
Other Income Expense
2.00
+803.93%
-0.28
+28.30%
-0.40
-111.77%
3.36
Other Non Operating Income Expenses
—
—
0.00
-96.99%
0.15
Gain On Sale Of Security
2.00
+803.93%
-0.28
-215.82%
0.25
-69.85%
0.81
Tax Provision
-0.09
+37.26%
-0.14
-5.48%
-0.13
+6.30%
-0.14
Tax Rate For Calcs
0.00
+0.00%
0.00
-31.33%
0.00
-58.58%
0.00
Tax Effect Of Unusual Items
0.01
+803.93%
-0.00
+51.33%
-0.00
-105.17%
0.07
Net Income Including Noncontrolling Interests
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Net Income From Continuing Operation Net Minority Interest
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Net Income From Continuing And Discontinued Operation
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Net Income Continuous Operations
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Net Income Discontinuous Operations
—
—
0.00
0.00
Normalized Income
-17.48
+17.17%
-21.10
-44.80%
-14.57
-50.58%
-9.68
Net Income Common Stockholders
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Diluted EPS
-0.12
+24.46%
-0.16
+3.78%
-0.17
—
Basic EPS
-0.12
+24.46%
-0.16
+3.78%
-0.17
—
Basic Average Shares
149.80
+22.39%
122.39
-90.96%
1,353.35
—
Diluted Average Shares
149.80
+22.39%
122.39
-90.96%
1,353.35
—
Diluted NI Availto Com Stockholders
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Amortization
—
—
—
0.89
Amortization Of Intangibles Income Statement
—
—
—
0.89
Depreciation Amortization Depletion Income Statement
—
—
—
1.70
Depreciation And Amortization In Income Statement
—
—
—
1.70
Depreciation Income Statement
—
—
—
0.81
Gain On Sale Of PPE
—
0.00
+100.00%
-0.00
+92.04%
-0.02
Rent And Landing Fees
—
0.15
-19.21%
0.18
-81.12%
0.96
Rent Expense Supplemental
—
0.15
-19.21%
0.18
-81.12%
0.96
Total Other Finance Cost
—
0.01
-55.75%
0.01
-94.13%
0.20
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total Assets
27.65
-3.20%
28.56
-36.42%
44.93
+10.20%
40.77
Current Assets
13.19
-1.00%
13.33
-53.67%
28.76
+23.78%
23.24
Cash Cash Equivalents And Short Term Investments
12.61
+4.17%
12.10
-47.58%
23.09
+7.83%
21.41
Cash And Cash Equivalents
12.61
+4.17%
12.10
-47.58%
23.09
+7.83%
21.41
Cash Financial
—
18.25
-20.96%
23.09
+7.83%
21.41
Other Short Term Investments
—
—
—
0.33
Receivables
0.13
-70.22%
0.43
-90.87%
4.67
+449.15%
0.85
Accounts Receivable
—
—
—
0.14
Gross Accounts Receivable
—
—
—
0.14
Other Receivables
0.10
-76.89%
0.42
-91.06%
4.65
+450.95%
0.84
Taxes Receivable
0.03
+211.99%
0.01
-35.16%
0.02
+173.37%
0.01
Accrued Interest Receivable
0.00
+11.28%
0.00
—
—
Prepaid Assets
0.46
-42.47%
0.80
-20.66%
1.01
+55.41%
0.65
Restricted Cash
—
—
0.00
-100.00%
0.33
Other Current Assets
—
—
—
0.70
Total Non Current Assets
14.46
-5.13%
15.24
-5.75%
16.17
-7.80%
17.53
Net PPE
0.22
-34.24%
0.33
-28.24%
0.46
-29.09%
0.65
Gross PPE
0.22
-42.11%
0.38
-40.66%
0.64
-65.81%
1.86
Accumulated Depreciation
-0.05
-1.07%
-0.05
+73.91%
-0.17
+85.67%
-1.21
Properties
—
0.00
0.00
0.00
Machinery Furniture Equipment
0.05
-0.09%
0.05
-3.62%
0.05
-38.22%
0.08
Other Properties
0.22
-33.74%
0.33
—
1.78
Leases
—
0.85
+45.37%
0.59
-67.05%
1.78
Goodwill And Other Intangible Assets
14.16
-4.50%
14.82
-5.09%
15.62
-6.97%
16.79
Goodwill
8.69
-0.05%
8.69
-1.78%
8.85
-4.99%
9.32
Other Intangible Assets
5.47
-10.81%
6.13
-9.42%
6.77
-9.43%
7.47
Investments And Advances
—
—
—
0.12
Other Investments
—
—
—
0.12
Non Current Prepaid Assets
—
—
—
0.09
Other Non Current Assets
0.08
-0.09%
0.08
-3.62%
0.08
-8.44%
0.09
Total Liabilities Net Minority Interest
10.16
+55.04%
6.55
+13.43%
5.78
+15.34%
5.01
Current Liabilities
3.83
+39.81%
2.74
+18.65%
2.31
+30.15%
1.77
Payables And Accrued Expenses
3.64
+42.47%
2.55
+33.16%
1.92
+40.60%
1.36
Payables
2.24
+55.89%
1.44
+34.39%
1.07
+38.56%
0.77
Accounts Payable
2.24
+55.89%
1.44
+34.39%
1.07
+38.56%
0.77
Other Payable
—
—
—
0.59
Current Accrued Expenses
1.39
+25.13%
1.11
+31.61%
0.85
+43.27%
0.59
Employee Benefits
—
0.02
+211.28%
0.01
+41.21%
0.01
Pensionand Other Post Retirement Benefit Plans Current
—
0.46
+62.31%
0.28
+0.76%
0.28
Current Debt And Capital Lease Obligation
0.16
+5.46%
0.15
+33.60%
0.11
-15.89%
0.13
Current Debt
0.03
-0.09%
0.03
—
—
Other Current Borrowings
0.03
-0.09%
0.03
—
—
Current Capital Lease Obligation
0.12
+7.07%
0.11
+3.49%
0.11
-15.89%
0.13
Other Current Liabilities
0.04
-4.63%
0.04
—
—
Total Non Current Liabilities Net Minority Interest
6.33
+65.98%
3.81
+9.96%
3.47
+7.22%
3.23
Long Term Debt And Capital Lease Obligation
0.12
-50.95%
0.24
-34.66%
0.37
-29.57%
0.52
Long Term Capital Lease Obligation
0.12
-50.95%
0.24
-34.66%
0.37
-29.57%
0.52
Non Current Pension And Other Postretirement Benefit Plans
—
—
—
0.01
Non Current Deferred Liabilities
0.96
-12.62%
1.10
-10.88%
1.24
-10.61%
1.38
Non Current Deferred Taxes Liabilities
0.96
-12.62%
1.10
-10.88%
1.24
-10.61%
1.38
Other Non Current Liabilities
0.59
-76.10%
2.47
+33.09%
1.86
+40.20%
1.32
Stockholders Equity
17.49
-20.54%
22.01
-43.78%
39.15
+9.48%
35.76
Common Stock Equity
17.49
-20.54%
22.01
-43.78%
39.15
+9.48%
35.76
Capital Stock
0.00
0.00
-100.00%
149.75
+4.80%
142.90
Common Stock
0.00
0.00
-100.00%
149.75
+4.80%
142.90
Share Issued
198.71
-86.47%
1,468.74
+8.53%
1,353.35
+34.31%
1,007.60
Ordinary Shares Number
198.71
-86.47%
1,468.74
+8.53%
1,353.35
+34.31%
1,007.60
Additional Paid In Capital
198.48
+5.83%
187.55
—
—
Retained Earnings
-177.98
-9.53%
-162.48
-36.29%
-119.22
-3.01%
-115.74
Gains Losses Not Affecting Retained Earnings
-3.01
+1.48%
-3.06
-135.50%
8.62
+0.16%
8.60
Other Equity Adjustments
-3.01
+1.48%
-3.06
—
4.75
Total Equity Gross Minority Interest
17.49
-20.54%
22.01
-43.78%
39.15
+9.48%
35.76
Total Capitalization
17.49
-20.54%
22.01
-43.78%
39.15
+9.48%
35.76
Working Capital
9.36
-11.55%
10.59
-59.98%
26.45
+23.25%
21.46
Invested Capital
17.52
-20.51%
22.04
-43.70%
39.15
+9.48%
35.76
Total Debt
0.27
-29.51%
0.39
-18.91%
0.48
-26.82%
0.65
Capital Lease Obligations
0.24
-32.27%
0.35
-25.86%
0.48
-26.82%
0.65
Net Tangible Assets
3.33
-53.62%
7.19
-69.46%
23.53
+24.03%
18.97
Tangible Book Value
3.33
-53.62%
7.19
-69.46%
23.53
+24.03%
18.97
Derivative Product Liabilities
4.66
0.00
—
—
Foreign Currency Translation Adjustments
—
—
—
3.85
Line Item Trend 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Cash Flow
-14.68
-0.29%
-14.64
+2.19%
-14.97
-164.22%
-5.66
Cash Flow From Continuing Operating Activities
-14.68
-0.29%
-14.64
+2.19%
-14.97
-164.22%
-5.66
Net Income From Continuing Operations
-15.49
+27.54%
-21.38
-42.84%
-14.97
-129.07%
-6.53
Depreciation Amortization Depletion
0.66
-0.03%
0.66
-13.10%
0.76
-40.28%
1.28
Depreciation And Amortization
0.66
-0.03%
0.66
-13.10%
0.76
-40.28%
1.28
Other Non Cash Items
-1.75
-347.96%
0.71
+11.05%
0.64
+134.80%
-1.83
Stock Based Compensation
0.81
-39.43%
1.35
-30.89%
1.95
+98.02%
0.98
Operating Gains Losses
-0.37
+34.21%
-0.56
-209.34%
0.51
+164.75%
-0.79
Gain Loss On Investment Securities
-0.34
—
—
—
Net Foreign Currency Exchange Gain Loss
-0.03
+95.09%
-0.56
-209.61%
0.51
+163.32%
-0.80
Gain Loss On Sale Of PPE
—
—
0.00
0.00
Change In Working Capital
1.45
-68.27%
4.58
+218.97%
-3.85
-414.04%
1.23
Change In Receivables
0.30
-92.77%
4.14
+203.14%
-4.01
-363.56%
1.52
Changes In Account Receivables
0.30
-92.77%
4.14
+15462.63%
-0.03
-205.18%
0.03
Change In Inventory
—
—
0.00
0.00
Change In Prepaid Assets
0.34
+94.69%
0.17
—
—
Change In Payables And Accrued Expense
1.08
+111.27%
0.51
-24.01%
0.67
+1517.23%
-0.05
Change In Accrued Expense
0.28
+101.23%
0.14
—
—
Change In Payable
0.80
+114.97%
0.37
-44.49%
0.67
+1517.23%
-0.05
Change In Account Payable
0.80
+114.97%
0.37
—
—
Change In Other Working Capital
-0.14
+0.00%
-0.14
-34.21%
-0.10
+43.28%
-0.18
Change In Other Current Assets
—
0.17
+141.40%
-0.41
-541.71%
-0.06
Change In Other Current Liabilities
-0.13
-26.41%
-0.10
0.00
0.00
Investing Cash Flow
—
0.32
-25.78%
0.43
+809.70%
-0.06
Cash Flow From Continuing Investing Activities
—
0.32
-25.78%
0.43
+809.70%
-0.06
Net PPE Purchase And Sale
—
0.00
-100.00%
0.12
+365.07%
0.03
Purchase Of PPE
—
0.00
+100.00%
-0.00
+3.70%
-0.00
Sale Of PPE
—
0.00
-100.00%
0.12
+349.88%
0.03
Capital Expenditure
—
—
-0.00
+3.70%
-0.00
Net Investment Purchase And Sale
—
0.00
-100.00%
0.30
+436.69%
-0.09
Purchase Of Investment
—
0.00
0.00
+100.00%
-0.09
Sale Of Investment
—
0.00
-100.00%
0.30
0.00
Net Business Purchase And Sale
—
—
0.00
0.00
Purchase Of Business
—
—
0.00
0.00
Financing Cash Flow
15.11
+291.58%
3.86
-79.22%
18.57
-21.67%
23.71
Cash Flow From Continuing Financing Activities
15.11
+291.58%
3.86
-79.22%
18.57
-21.67%
23.71
Net Issuance Payments Of Debt
—
-0.11
+11.61%
-0.12
+98.66%
-8.92
Repayment Of Debt
—
-0.11
+11.61%
-0.12
+98.66%
-8.92
Long Term Debt Payments
—
-0.11
+11.61%
-0.12
+98.66%
-8.92
Net Long Term Debt Issuance
—
-0.11
+11.61%
-0.12
+98.66%
-8.92
Net Common Stock Issuance
10.11
+162.07%
3.86
-82.95%
22.63
-31.30%
32.94
Common Stock Payments
—
—
—
-0.42
Repurchase Of Capital Stock
—
—
—
-0.42
Proceeds From Stock Option Exercised
5.00
0.00
—
—
Net Other Financing Charges
—
-1.13
+71.37%
-3.94
-1160.64%
-0.31
Changes In Cash
0.43
+103.97%
-10.78
-367.32%
4.03
-77.58%
17.98
Effect Of Exchange Rate Changes
0.08
+131.57%
-0.24
+55.50%
-0.55
-5477.45%
-0.01
Beginning Cash Position
12.18
-47.50%
23.21
+18.36%
19.61
+470.01%
3.44
End Cash Position
12.69
+4.15%
12.18
-47.24%
23.09
+7.83%
21.41
Free Cash Flow
-14.68
-0.29%
-14.64
+2.20%
-14.97
-164.19%
-5.67
Interest Paid Supplemental Data
—
—
—
0.73
Cash Flowsfromusedin Operating Activities Direct
—
—
—
-5.66
Classesof Cash Payments
—
—
—
-7.61
Classesof Cash Receiptsfrom Operating Activities
—
—
—
2.49
Common Stock Issuance
10.11
+162.07%
3.86
-82.95%
22.63
-31.30%
32.94
Interest Paid Direct
—
—
—
-0.55
Interest Received CFI
—
0.32
+3586.64%
0.01
+179.91%
0.00
Issuance Of Capital Stock
10.11
+162.07%
3.86
-82.95%
22.63
-31.30%
32.94
Paymentsto Suppliersfor Goodsand Services
—
—
—
-7.61
Receiptsfrom Customers
—
—
—
0.30
Receiptsfrom Government Grants
—
—
—
2.19
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category